Myoviridae phage PDX kills enteroaggregative Escherichia coli without human microbiome dysbiosis

INTRODUCTION: Bacteriophage therapy can be developed to target emerging diarrhoeal pathogens, but doing so in the absence of microbiome disruption, which occurs with antibiotic treatment, has not been established. AIM: Identify a therapeutic bacteriophage that kills diarrhoeagenic enteroaggregative...

Descripción completa

Detalles Bibliográficos
Autores principales: Cepko, Leah C. S., Garling, Eliotte E., Dinsdale, Madeline J., Scott, William P., Bandy, Loralee, Nice, Tim, Faber-Hammond, Joshua, Mellies, Jay L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Microbiology Society 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431101/
https://www.ncbi.nlm.nih.gov/pubmed/32011231
http://dx.doi.org/10.1099/jmm.0.001162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431101/
https://www.ncbi.nlm.nih.gov/pubmed/32011231
http://dx.doi.org/10.1099/jmm.0.001162

Ejemplares similares